Xylem Inc.

Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Xylem Inc. (NYSE: XYL) resulting from allegations that Xylem may have issued materially misleading business information to the investing public.

If you purchased Xylem securities and would like to join the prospective action, please click “Join This Class Action.”

If you purchased Xylem securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Details of investigation:

On August 9, 2023, before the market opened, market analyst Spruce Point Capital Management, LLC released a report entitled “A Leak in the Bull Case”, which, among other things, alleged that certain financial figures which had been presented to investors regarding Xylem’s 2023 acquisition of Evoqua were false.

On this news, the price of Xylem shares declined by $2.82 per share, or 2.68%, to close at $102.33 per share on August 9, 2023.

Follow us on:
Company Name: Xylem Inc.
Stock Symbol: XYL
Class Period: N/A
Court: N/A

Why Rosen Law

The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.

Investors should carefully identify and select experienced counsel with a track record of success leading securities class actions. Often other firms issue press releases about class actions yet do not have comparable experience or resources.

Institutional Shareholders Services ranked the Rosen Law Firm # 1 for the number of securities class action recoveries in 2017.

The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.

Scroll to Top